Press Releases

Date Title and Summary
Toggle Summary Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON, Wis. , Aug.
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results
14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance MADISON, Wis. , Aug. 14, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024 .     Fourth Quarter Fiscal 2024 Summary Net revenue of
Toggle Summary Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology
New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy Treatments MADISON, Wis. and DAYTONA BEACH, Fla. , Aug. 13, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Halifax Health , in
Toggle Summary Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024
MADISON, Wis. , July 31, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2024, ended June 30, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 14, 2024 .
Toggle Summary Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
The Radixact System will be supplied with ClearRT ® , Synchrony ® , and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speed Heidelberg University Hospital is recognized worldwide for excellence in patient care and practice changing research MADISON, Wis.
Toggle Summary Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities.
Toggle Summary Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
MADISON, Wis. , June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray   Precision ® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA).
Toggle Summary Accuray to Participate in the Jefferies Global Healthcare Conference 2024
MADISON, Wis. , May 22, 2024 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024. The management team is scheduled to participate in a fireside chat on Wednesday, June 5, 2024 at 7:30am EDT / 4:30am PDT     A live
Toggle Summary Accuray Reports Fiscal 2024 Third Quarter Financial Results
MADISON, Wis. , May 1, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024 .     Third Quarter Fiscal 2024 Summary Net revenue of $101.1 million decreased 14 percent from the same period in the prior
Toggle Summary Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
  The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin ( U.S. ), Tokyo, Japan and Tianjin, China     Each facility offers a range of educational opportunities designed to advance patient care using the Accuray CyberKnife ® and Radixact ® Systems

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.